Abortion services and providers in Canada in 2019: results of a national survey

RM Renner, M Ennis, D Contandriopoulos… - … Open Access Journal, 2022 - cmajopen.ca
Background: Since 2016, abortion care has undergone several important changes,
particularly related to the provision of medical abortion using mifepristone. We aimed to …

Barriers and facilitators to the implementation of first trimester medical abortion with mifepristone in the province of Québec: a qualitative investigation

MS Wagner, S Munro, ES Wilcox, C Devane… - Journal of Obstetrics and …, 2020 - Elsevier
Objective Mifepristone became available in Canada in January 2017, but provincial medical
policy delayed its use for medical abortion (MA) in Québec for 1 year. The objective of this …

Trends in medication abortion provision before and after the introduction of mifepristone: a study of the National Abortion Federation's Canadian member services

A Yalahow, J Doctoroff, A Mark, AM Foster - Contraception, 2020 - Elsevier
Objective We analyzed trends in medication abortion provision before and after the 2017
introduction of mifepristone in Canada. Methods We reviewed 2016–2018 abortion services …

Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey

M Ennis, R Renner, E Guilbert, WV Norman, H Pymar… - Contraception, 2022 - Elsevier
Abstract Objective To explore the Canadian first-trimester medication abortion (MA)
workforce and their clinical care following the introduction of mifepristone in 2017, updated …

[HTML][HTML] Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers

C Devane, RM Renner, S Munro, É Guilbert… - Pilot and feasibility …, 2019 - Springer
Background Direct primary care provision of first-trimester medical abortion could potentially
address inequitable abortion access in Canada. However, when Health Canada approved …

Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients

KI Vogel, KJ LaRoche, J El-Haddad, A Chaumont… - Contraception, 2016 - Elsevier
Abstract Introduction Although Canada decriminalized abortion in 1988, significant
disparities in access to services and an uneven geographic distribution of providers persists …

Perspectives among Canadian physicians on factors influencing implementation of mifepristone medical abortion: a national qualitative study

S Munro, E Guilbert, MS Wagner… - The Annals of Family …, 2020 - Annals Family Med
PURPOSE Access to family planning health services in Canada has been historically
inadequate and inequitable. A potential solution appeared when Health Canada approved …

How did the introduction of mifepristone impact the availability of abortion care in Ottawa? A qualitative study with abortion patients

KJ LaRoche, IN Labeca-Gordon, AM Foster - Facets, 2020 - facetsjournal.com
In 2017, mifepristone and misoprostol became available for early pregnancy termination as
the combination pack Mifegymiso® in Ottawa, Ontario, Canada. We conducted 40 semi …

[HTML][HTML] Medical abortion in Canada: behind the times

S Dunn, R Cook - CMAJ, 2014 - Can Med Assoc
Commentary study that mapped women's travel to abortion clinics showed that women from
Atlantic Canada and those from rural and northern communities often travel long distances …

Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project

KJ LaRoche, A Wylie, M Persaud, AM Foster - Contraception, 2022 - Elsevier
Objectives Following the 2017 introduction of mifepristone in Canada and both ensuing
regulatory changes and increased demand for medication abortion care, Planned …